Noticias de AIM_US

Noticias del mercado

Últimas noticias sobre AIM_US — 148 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: AIM_US ✕ 148 resultados
16/04/2026 AIM_US — Bitget
AIM ImmunoTech Inc. announces that its core drug Ampligen® has reached a critical value inflection point in the field of pancreatic cancer treatment.
16/04/2026 AIM_US — Investing.com
AIM ImmunoTech advances Phase 3 planning for pancreatic cancer By Investing.com
16/04/2026 AIM_US — GlobeNewswire
AIM ImmunoTech Enters Pivotal Value Inflection Phase with
15/04/2026 AIM_US — Bitget ES ← EN
AIM ImmunoTech Inc. anuncia que su fármaco principal Ampligen® ha alcanzado un punto de inflexión de valor crítico en el campo del tratamiento del cáncer de páncreas.
14/04/2026 AIM_US — ChartMill
AIM ImmunoTech Provides Routine Update on Annual Filings
13/04/2026 AIM_US — Weekly Voice
AIM ImmunoTech Provides Routine Update on Annual Filings
13/04/2026 AIM_US — GlobeNewswire
AIM ImmunoTech Provides Routine Update on Annual Filings
13/04/2026 AIM_US — Bitget ES ← EN
AIM ImmunoTech proporciona actualización de rutina sobre las presentaciones anuales
13/04/2026 AIM_US — GlobeNewswire
AIM ImmunoTech Provides Routine Update on Annual Filings
13/04/2026 AIM_US — Sahm
Stock Ratings | Down 54%! Morgan Stanley lowered its price target for Robinhood (HOOD) from $147 to $95; Benchmark raised its price target for Intel (INTC) to $76
13/04/2026 AIM_US — Quiver Quantitative
AIM ImmunoTech Inc. Reports Audit Findings with Going Concern Emphasis and Positive Clinical Trial Progress for Ampligen in Pancreatic Cancer Treatment
13/04/2026 AIM_US — GlobeNewswire
AIM ImmunoTech Provides Routine Update on Annual Filings
13/04/2026 AIM_US — Stock Titan
Why AIM had to disclose a going concern note in its 2025 audit
13/04/2026 AIM_US — Yahoo Finance
AIM ImmunoTech Provides Routine Update on Annual Filings
11/04/2026 AIM_US — Minichart
AIM ImmunoTech Inc. 8-K Filing Details Equity Distribution Agreement Amendment and NYSE American Listing
10/04/2026 AIM_US — Investing.com
AIM ImmunoTech amends equity distribution agreement to remove share sale limit
10/04/2026 AIM_US — GuruFocus
AIM Stock Target Price Lowered by Ascendiant Capital | AIM Stock News
10/04/2026 AIM_US — Stock Titan
AIM ImmunoTech (NYSE: AIM) lifts cap on at-the-market stock sales
10/04/2026 AIM_US — Stock Titan
AIM ImmunoTech (NYSE American: AIM) ups ATM capacity to $3.41M under S‑3
10/04/2026 AIM_US — Investing.com
AIM ImmunoTech amends equity distribution agreement to remove share sale limit

Página 4 de 8

keyboard_arrow_up